Using publicly available RNA sequencing data profiles, including more than 500,000 single cells from 15 AML patients and tissues from 9 healthy patients, investigators computationally identified 2 potential new targets, CSF1R and CD86. This evidence concerns the gene CSF1R and acute myeloid leukemia.